Lan Coffman

4.5k total citations · 2 hit papers
48 papers, 2.8k citations indexed

About

Lan Coffman is a scholar working on Oncology, Molecular Biology and Reproductive Medicine. According to data from OpenAlex, Lan Coffman has authored 48 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Oncology, 12 papers in Molecular Biology and 12 papers in Reproductive Medicine. Recurrent topics in Lan Coffman's work include Cancer Cells and Metastasis (18 papers), Ovarian cancer diagnosis and treatment (11 papers) and Endometrial and Cervical Cancer Treatments (8 papers). Lan Coffman is often cited by papers focused on Cancer Cells and Metastasis (18 papers), Ovarian cancer diagnosis and treatment (11 papers) and Endometrial and Cervical Cancer Treatments (8 papers). Lan Coffman collaborates with scholars based in United States, New Zealand and Germany. Lan Coffman's co-authors include Suzy V. Torti, Frank M. Torti, Mary Ann Knovich, Ronald J. Buckanovich, Wei Wang, Ralph B. D’Agostino, Huda I. Atiya, Leonard Frisbie, Chelsea Chandler and Derek Parsonage and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Lan Coffman

43 papers receiving 2.7k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Serum ferritin: Past, present and future

2010 639 citations Wei Wang, Mary Ann Knovich et al. Biochimica et Biophysica Acta (BBA) - General Subjects profile →
B cell signatures and tertiary lymphoid structures contribute to outcome in head and neck squamous cell carcinoma

2021 230 citations Ayana T. Ruffin, Anthony R. Cillo et al. Nature Communications profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Lan Coffman	848	844	811	592	450	48	2.8k
Naohisa Tomosugi	1.2k 1.4×	566 0.7×	317 0.4×	761 1.3×	123 0.3×	106	2.9k
Josep Nomdedéu	1.6k 1.9×	1.4k 1.7×	736 0.9×	707 1.2×	315 0.7×	131	3.5k
Gregor Hoermann	1.0k 1.2×	770 0.9×	525 0.6×	763 1.3×	178 0.4×	145	3.0k
Alessandra Romano	857 1.0×	890 1.1×	721 0.9×	321 0.5×	189 0.4×	187	2.6k
Coen Maas	1.3k 1.6×	778 0.9×	213 0.3×	1.8k 3.0×	220 0.5×	93	3.6k
Lars C. Petersen	2.0k 2.4×	951 1.1×	307 0.4×	761 1.3×	737 1.6×	93	3.6k
Graham Molineux	1.8k 2.1×	824 1.0×	1.1k 1.3×	671 1.1×	112 0.2×	82	3.6k
Alan R. Stafford	935 1.1×	843 1.0×	173 0.2×	348 0.6×	233 0.5×	74	2.6k
Satoshi Iyama	432 0.5×	937 1.1×	525 0.6×	570 1.0×	153 0.3×	111	2.3k
Koji Miyanishi	374 0.4×	1.5k 1.8×	1.0k 1.3×	622 1.1×	449 1.0×	151	4.0k

Countries citing papers authored by Lan Coffman

Since Specialization

Citations

This map shows the geographic impact of Lan Coffman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lan Coffman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lan Coffman more than expected).

Fields of papers citing papers by Lan Coffman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lan Coffman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lan Coffman. The network helps show where Lan Coffman may publish in the future.

Co-authorship network of co-authors of Lan Coffman

This figure shows the co-authorship network connecting the top 25 collaborators of Lan Coffman. A scholar is included among the top collaborators of Lan Coffman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lan Coffman. Lan Coffman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Soong, T. Rinda, Sarah E. Taylor, Lan Coffman, et al.. (2025). Adjuvant therapy in early uterine serous carcinoma. American Journal of Epidemiology. 195(1). 198–204. 1 indexed citations

Kunning, Sheryl, Huda I. Atiya, Ayana T. Ruffin, et al.. (2024). The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions. Cancer Cell. 42(11). 1864–1881.e5. 24 indexed citations

Epperly, Michael W., Renee Fisher, Wen‐Chi Hou, et al.. (2024). Genetically Engineered Probiotic Limosilactobacillus reuteri Releasing IL-22 (LR-IL-22) Modifies the Tumor Microenvironment, Enabling Irradiation in Ovarian Cancer. Cancers. 16(3). 474–474. 4 indexed citations

Konecny, Gottfried E., Kathleen N. Moore, Coriolan Lebreton, et al.. (2024). Patient-reported outcome results from phase III MIRASOL trial of mirvetuximab soravtansine versus investigator's choice of chemotherapy in FRα-positive, platinum-resistant ovarian cancer. Gynecologic Oncology. 190. S11–S12. 1 indexed citations

Mahdi, Haider, Kristine Cooper, Sarah Taylor, et al.. (2024). 614 T-regulatory cell depletion with E7777 combined with pembrolizumab in patients with recurrent solid tumors: phase I trial. Regular and Young Investigator Award Abstracts. A706–A706.

Wang, Hui, et al.. (2023). Impact of Race and Socioeconomic Factors on Clinical Outcomes in Cervical and Endometrial Cancer Patients Treated with Brachytherapy. International Journal of Radiation Oncology*Biology*Physics. 117(2). e534–e535.

Soong, T. Rinda, Madeleine Courtney‐Brooks, Sarah E. Taylor, et al.. (2023). The role of adjuvant treatment for early-stage uterine clear cell carcinomas. Gynecologic Oncology. 170. 77–83. 4 indexed citations

Atiya, Huda I., Leonard Frisbie, Nicole Donnellan, et al.. (2022). Endometriosis-Associated Mesenchymal Stem Cells Support Ovarian Clear Cell Carcinoma through Iron Regulation. Cancer Research. 82(24). 4680–4693. 30 indexed citations

Coffman, Lan, Leonard Frisbie, Daniel P. Normolle, et al.. (2022). Phase I trial of ribociclib with platinum chemotherapy in ovarian cancer. JCI Insight. 7(18). 13 indexed citations

10.

Buckanovich, Ronald J., Madeleine Courtney‐Brooks, Paniti Sukumvanich, et al.. (2022). Clinical factors associated with failed sentinel lymph node mapping in endometrial cancer. Gynecologic Oncology Reports. 44. 101080–101080. 4 indexed citations

11.

Cascio, Sandra, Chelsea Chandler, Bingsi Gao, et al.. (2021). Cancer-associated MSC drive tumor immune exclusion and resistance to immunotherapy, which can be overcome by Hedgehog inhibition. Science Advances. 7(46). eabi5790–eabi5790. 54 indexed citations

12.

Beriwal, Sushil, Rohit Bhargava, J. Berger, et al.. (2021). Cost-effectiveness analysis of tumor molecular classification in high-risk early-stage endometrial cancer. Gynecologic Oncology. 164(1). 129–135. 17 indexed citations

13.

Ruffin, Ayana T., Anthony R. Cillo, Tracy Tabib, et al.. (2021). B cell signatures and tertiary lymphoid structures contribute to outcome in head and neck squamous cell carcinoma. Nature Communications. 12(1). 3349–3349. 230 indexed citations breakdown →

14.

Atiya, Huda I., et al.. (2021). An Orthotopic Mouse Model of Ovarian Cancer using Human Stroma to Promote Metastasis. Journal of Visualized Experiments. 7 indexed citations

15.

Fan, Huihui, Huda I. Atiya, Yeh Wang, et al.. (2020). Epigenomic Reprogramming toward Mesenchymal-Epithelial Transition in Ovarian-Cancer-Associated Mesenchymal Stem Cells Drives Metastasis. Cell Reports. 33(10). 108473–108473. 44 indexed citations

16.

McLean, Karen, Lijun Tan, Lan Coffman, et al.. (2018). Leukemia inhibitory factor functions in parallel with interleukin-6 to promote ovarian cancer growth. Oncogene. 38(9). 1576–1584. 64 indexed citations

17.

Coffman, Lan, Daniela Burgos-Ojeda, Rong Wu, et al.. (2016). New models of hematogenous ovarian cancer metastasis demonstrate preferential spread to the ovary and a requirement for the ovary for abdominal dissemination. Translational research. 175. 92–102.e2. 68 indexed citations

18.

Miller, Lance D., Lan Coffman, Jeff W. Chou, et al.. (2011). An Iron Regulatory Gene Signature Predicts Outcome in Breast Cancer. Cancer Research. 71(21). 6728–6737. 169 indexed citations

19.

Wang, Wei, Mary Ann Knovich, Lan Coffman, Frank M. Torti, & Suzy V. Torti. (2010). Serum ferritin: Past, present and future. Biochimica et Biophysica Acta (BBA) - General Subjects. 1800(8). 760–769. 639 indexed citations breakdown →

20.

Knovich, Mary Ann, et al.. (2008). Ferritin for the clinician. Blood Reviews. 23(3). 95–104. 455 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact